These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9745533)

  • 1. Liposomal tacrolimus and intestinal drug concentration.
    Dutta S; Mezei M; Lee TD; McAlister VC
    Transplant Proc; 1998 Sep; 30(6):2651-2. PubMed ID: 9745533
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic characteristics of two types of liposomal FK 506.
    Yagura K; Nakajima Y; Ko S; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1390-1. PubMed ID: 8658708
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
    Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
    Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal tacrolimus: drug migration within blood compartments.
    McAlister VC
    Transplant Proc; 1998 Jun; 30(4):1000-1. PubMed ID: 9636404
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity.
    McAlister VC; Keshavamurthy M; Lee TD
    Transplant Proc; 1999; 31(1-2):1110. PubMed ID: 10083495
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus.
    Alessiani M; Regazzi M; Abbiati F; Ferrari P; Molinaro M; Iacona I; Klersy C; Viezzoli A; Fayer F; Pileggi A; Zitelli E; Burroni B; Scandone M; Dionigi P; Zonta A
    Transplant Proc; 2000 Sep; 32(6):1214-5. PubMed ID: 10995915
    [No Abstract]   [Full Text] [Related]  

  • 7. Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation.
    Ko S; Nakajima Y; Kanehiro H; Hisanaga M; Horikawa M; Aomatsu Y; Yagura K; Kin T; Ohyama T; Nishio K; Yamada T; Nakano H
    Transplant Proc; 1997; 29(1-2):529-31. PubMed ID: 9123117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of a new strength tacrolimus capsule under development.
    Bekersky I; Dressler D; Boswell GW; Fergen B; Tracewell W; Mekki Q
    Transplant Proc; 1998 Jun; 30(4):1457-9. PubMed ID: 9636591
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation.
    Regazzi MB; Alessiani M; Reggiani P; Gatti S; Spada M; Iacona I; Rossi G; Tzakis A
    Transplant Proc; 1997 May; 29(3):1857-60. PubMed ID: 9142302
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
    Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
    Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
    Yigitaslan S; Erol K; Cengelli C
    Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 14. Trough levels of tacrolimus.
    Stolk LM; Van Duijnhoven EM; Christiaans MH; van Hooff JP
    Ther Drug Monit; 2002 Aug; 24(4):573; author reply 573-4. PubMed ID: 12142646
    [No Abstract]   [Full Text] [Related]  

  • 15. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.
    Ben Fredj N; Woillard JB; Debord J; Chaabane A; Boughattas N; Marquet P; Saint-Marcoux F; Aouam K
    Exp Clin Transplant; 2016 Aug; 14(4):394-400. PubMed ID: 27506258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily tacrolimus in living donor liver transplant recipients.
    Sugawara Y; Miyata Y; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
    Biosci Trends; 2011 Aug; 5(4):156-8. PubMed ID: 21914950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tacrolimus and mycophenolic acid are altered, but recover at different times during hepatic regeneration in rats.
    Tian H; Ou J; Strom SC; Venkataramanan R
    Drug Metab Dispos; 2005 Mar; 33(3):329-35. PubMed ID: 15523045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
    Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.